As expected, mutations in MYC, ID3 and CCND3 were more frequent in Burkitt Lymphoma than in DLBCL or follicular lymphoma, and additionally we also detected the significant enrichments of Burkitt Lymphomas in TP53 and FBXO11 mutations. This evidence concerns the gene TP53 and Burkitt lymphoma.